NDC 16729-044-10 - ATORVASTATIN CALCIUM
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 16729-044
- Requested NDC
- 16729-044-10
- Package NDCs from labels
- 16729-044-10, 16729-044-15, 16729-044-01, 16729-044-16, 16729-044-17
- Manufacturer
- NuCare Pharmaceuticals,Inc.
- Effective date
- 2026-03-05
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| ATORVASTATIN CALCIUM - NuCare Pharmaceuticals,Inc. | NuCare Pharmaceuticals,Inc. | 2026-03-05 | HUMAN PRESCRIPTION DRUG LABEL |
| ATORVASTATIN CALCIUM - Northwind Health Company, LLC | Northwind Health Company, LLC | 2026-01-01 | HUMAN PRESCRIPTION DRUG LABEL |
| ATORVASTATIN CALCIUM - Accord Healthcare Inc. | Intas Pharmaceuticals Limited | Accord Healthcare Inc. | Intas Pharmaceuticals Limited | 2025-10-06 | HUMAN PRESCRIPTION DRUG LABEL |
| ATORVASTATIN CALCIUM - Bryant Ranch Prepack | Bryant Ranch Prepack | 2024-10-31 | HUMAN PRESCRIPTION DRUG LABEL |
| ATORVASTATIN CALCIUM - NuCare Pharmaceuticals,Inc. | NuCare Pharmaceuticals,Inc. | 2024-06-20 | HUMAN PRESCRIPTION DRUG LABEL |
| ATORVASTATIN CALCIUM - REMEDYREPACK INC. | REMEDYREPACK INC. | 2024-02-23 | HUMAN PRESCRIPTION DRUG LABEL |
| ATORVASTATIN CALCIUM - Preferred Pharmaceuticals Inc. | Preferred Pharmaceuticals Inc. | 2023-03-31 | HUMAN PRESCRIPTION DRUG LABEL |
| ATORVASTATIN CALCIUM - Proficient Rx LP | Proficient Rx LP | 2022-05-01 | HUMAN PRESCRIPTION DRUG LABEL |
| ATORVASTATIN CALCIUM - Quality Care Products, LLC | Quality Care Products, LLC | 2021-09-22 | HUMAN PRESCRIPTION DRUG LABEL |
| ATORVASTATIN CALCIUM - A-S Medication Solutions | A-S Medication Solutions | 2021-05-18 | HUMAN PRESCRIPTION DRUG LABEL |
| ATORVASTATIN CALCIUM - RPK Pharmaceuticals, Inc. | RPK Pharmaceuticals, Inc. | 2020-12-21 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 16729-044-01 | ATORVASTATIN CALCIUM | 100 in 1 BOTTLE | TABLET, FILM COATED | 100 | 13 | |
| 16729-044-10 | ATORVASTATIN CALCIUM | 30 in 1 BOTTLE | TABLET, FILM COATED | 30 | 13 | |
| 16729-044-15 | ATORVASTATIN CALCIUM | 90 in 1 BOTTLE | TABLET, FILM COATED | 90 | 13 | |
| 16729-044-16 | ATORVASTATIN CALCIUM | 500 in 1 BOTTLE | TABLET, FILM COATED | 500 | 13 | |
| 16729-044-17 | ATORVASTATIN CALCIUM | 1000 in 1 BOTTLE | TABLET, FILM COATED | 1000 | 13 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 16729-044-15 | EA - Each | 16729-044 | 8059a8d9-db16-41e7-958d-afce0d8378cd | 1 | 2021-06-02 |
| 16729-044-17 | EA - Each | 16729-044 | f9b79a87-df9c-4ff9-a50b-8381c28bfd4c | 1 | 2018-08-13 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Dolce and Gabbana Everlast Foundation SPF 20 04C Light | OCTISALATE, OCTOCRYLENE, TITANIUM DIOXIDE, ZINC OXIDE | Dolce & Gabbana Beauty S.R.L | f055cd51-7b1d-43df-8990-8f60ba1eb91c | 2025-08-04 | Warnings | 15FIX9V2JP |
| Dolce and Gabbana Everlast Foundation SPF 20 07N Light | OCTISALATE, OCTOCRYLENE, TITANIUM DIOXIDE, ZINC OXIDE | Dolce & Gabbana Beauty S.R.L | d4c76bc5-205b-45fd-8a02-4f4b17458503 | 2025-08-04 | Warnings | 15FIX9V2JP |
| Atorvastatin Calcium | ATORVASTATIN CALCIUM | Teva Pharmaceuticals, Inc. | d3497ad6-b549-4144-b57f-b2088ad80b09 | 2025-08-01 | Warnings, Adverse reactions | 617311 617310 259255 617312 48A5M73Z4Q |
| ATORVASTATIN CALCIUM | ATORVASTATIN CALCIUM | Camber Pharmaceuticals, Inc. | 25c8f92f-9cb6-482b-82e1-16ad7c94e7b3 | 2025-07-28 | Warnings, Adverse reactions | 617311 617310 259255 617312 48A5M73Z4Q |
| Neutrogena Mineral Invisible Daily Defense Face Sunscreen Broad Spectrum SPF 30 | TITANIUM DIOXIDE, ZINC OXIDE | Kenvue Brands LLC | 003123d2-9675-fdd2-e063-6294a90a0130 | 2025-07-28 | Warnings | 15FIX9V2JP |
| Neutrogena Mineral Ultra Sheer Face SPF 70 | TITANIUM DIOXIDE, ZINC OXIDE | Kenvue Brands LLC | 20e0badf-fe25-1d27-e063-6294a90a7cfe | 2025-07-28 | Warnings | 15FIX9V2JP |
| Dolce and Gabbana Everlast Foundation SPF 20 01N Light | OCTISALATE, OCTOCRYLENE, TITANIUM DIOXIDE, ZINC OXIDE | Dolce & Gabbana Beauty S.R.L | 2ccf4e45-4cec-417d-9f4c-28f376025f1d | 2025-07-25 | Warnings | 15FIX9V2JP |
| Sunscreen | TITANIUM DIOXIDE 6.8% | Baxter of California, LLC | 146030bc-2bf4-25ea-e063-6294a90a4613 | 2025-07-24 | Warnings | 15FIX9V2JP |
| La Defense Broad Spectrum SPF 30 Mineral Sunscreen | ZINC OXIDE, TITANIUM DIOXIDE | Luzern Laboratories, Inc | 3f00befa-415d-415d-89e1-6ba8770ba51e | 2025-07-21 | Warnings | 15FIX9V2JP |
| Atorvastatin Calcium | ATORVASTATIN CALCIUM | Mylan Institutional Inc. | 7c1083b9-7a20-475d-ba12-4f5d0b53e601 | 2025-07-18 | Warnings, Adverse reactions | 617311 617310 259255 617312 48A5M73Z4Q |
| Gas-X Total Relief Maximum Strength | CALCIUM CARBONATE, SIMETHICONE | Haleon US Holdings LLC | edb0f11a-bdb7-484d-9257-09ff47b0fca4 | 2025-07-15 | Warnings | H0G9379FGK |
| Amarte ULTRA VEIL Daily | SUNSCREEN | Amarte USA LLC | 39e9ca98-d0e8-6b8f-e063-6394a90aa366 | 2025-07-15 | Warnings | 15FIX9V2JP |
| Amarte ULTRA VEIL BB Fair | SUNSCREEN | Amarte USA LLC | 39e87950-4103-c2eb-e063-6394a90a0552 | 2025-07-15 | Warnings | 15FIX9V2JP |
| leader acid reducer complete | FAMOTIDINE, CALCIUM CARBONATE, MAGNESIUM HYDROXIDE | Cardinal Health 110, LLC. dba Leader | 6a492dd2-61f1-4020-bebd-fcc8e5647207 | 2025-07-08 | Warnings | H0G9379FGK |
| Dual Action Complete | FAMOTIDINE, CALCIUM CARBONATE, MAGNESIUM HYDROXIDE | Kroger Company | bf2fcb88-418f-4d5d-85ba-ec165a53ab04 | 2025-07-07 | Warnings | H0G9379FGK |
| MGC Health Antacid Soft Chews Cherry Flavor | CALCIUM CARBONATE | Xiamen Kang Zhongyuan Biotechnology Co., Ltd. | 3958ec0a-8f32-6918-e063-6294a90ac1c4 | 2025-07-07 | Warnings | H0G9379FGK |
| ATORVASTATIN CALCIUM | ATORVASTATIN CALCIUM | NuCare Pharmaceuticals, Inc. | 395dbb88-5889-c91c-e063-6394a90a8daf | 2025-07-07 | Warnings, Adverse reactions | 259255 48A5M73Z4Q |
| Equate Acid Reducer Complete | FAMOTIDINE, CALCIUM CARBONATE, MAGNESIUM HYDROXIDE | Wal-Mart Stores Inc | cb683c1c-db81-40a9-9ec5-f8dfa0dcf812 | 2025-07-07 | Warnings | H0G9379FGK |
| Dual Action Complete | FAMOTIDINE, CALCIUM CARBONATE, MAGNESIUM HYDROXIDE | H E B | ea712fc4-7f27-4556-b1b8-028f3f6ce57a | 2025-07-07 | Warnings | H0G9379FGK |
| DG Health acid reducer complete | FAMOTIDINE, CALCIUM CARBONATE AND MAGNESIUM HYDROXIDE | Dolgencorp, LLC | 95c2c515-0f31-49d9-b799-7aaded81a37c | 2025-07-07 | Warnings | H0G9379FGK |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.